Atlas Trials

Changes in Lipids and Lipoproteins in HIV Infected Women After Switch From Protease Inhibitor to Raltegravir

Clinical trial NCT02097108 · COMPLETED

Trial details

NCT number
NCT02097108
Sponsor
Arbeitsgemeinschaft medikamentoese Tumortherapie
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV Infections
Start date
2014-05-01
Primary completion
2015-12-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.